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Lipoprotein Receptors: Minireview
Signaling Functions in the Brain?
brain has a characteristic architecture of packed layers
of cells with specific functional identities. In VLDLR2
apoER22, reln2, and dab12 brains, these layers are dis-
Jonathan A. Cooper and Brian W. Howell
Fred Hutchinson Cancer Research Center
Seattle, Washington 98109
organized.
For example, the Purkinje cells of the cerebellum nor-
mally migrate outward from an origin near the fourthWhile some nutrients enter cells through transporters,
ventricle, to form a thin layer beneath cerebellar granuleothers, including iron and cholesterol, are actively im-
cell precursors. In the mutants, the Purkinje cells initiateported into cells by specialized receptors. These import
migration but remain clustered deeper in the cerebellarreceptors continuously recycle between the cell surface
primordium (Lambert de Rouvroit and Goffinet, 1998;and intracellular vesicles. Cargo is carried from the cell
Trommsdorff et al., 1999). Since the proliferation of gran-surface via clathrin-coated pits to endosomes, acidified
ule cells requires mitogens, such as Sonic hedgehog,compartments where the cargo is released. The recep-
made by the Purkinje cells, the number of granule cellstors then return to the cell surface for another cycle of
is markedly reduced in the mutants, and the mutantimport. One import receptor, the low density lipoprotein
cerebella are about five times smaller than usual.receptor (LDLR), has been intensively studied because
The development of the cortex is orchestrated differ-its malfunction is a cause of atherosclerosis. The LDLR
ently (Pearlman et al., 1998). Early neurons form twois essential to transport LDL (complexes of cholesterol,
layers, an inner subplate and an outer layer of Cajal-triglycerides, and specific apolipoproteins) out of the
Retzius (CR) neurons. Later neurons, which will form theplasma, as first shown by the hallmark analysis of familial
cortical plate of the embryonic cortex, move throughhypercholesterolemia by Brown and Goldstein. In sub-
the subplate layer and come to rest below the CR cells.sequent years, other import receptors related to the
As each subsequent cortical plate neuron migrates, itLDLR have been discovered, and the LDLR superfamily
bypasses its predecessors, coming to rest immediatelynow includes at least five mammalian and several inver-
below the CR neurons. In the mutants, the migratingtebrate proteins. It has become clear that most of the
cells neither penetrate between subplate neurons nornew members of the family do not have a primary func-
overtake their brethren (Pearlman et al., 1998; Rice ettion in LDL import, and instead bind and import multiple
al., 1998). The CR, subplate, and early cortical plateligands (see Figure 1). Indeed, the ability to transport
neurons remain superficial to subsequent generationsLDL is a recent evolutionary adaptation of an ancient
of cortical plate neurons, which pile-up underneath themreceptor family. Even so, there have been few reasons
to suspect that these proteins regulate cellular events
during development. Thus, it is remarkable to discover
that the ablation of two LDLR family members (VLDLR
and ApoER2) causes very specific alterations in the de-
velopment of the nervous system (Trommsdorff et al.,
1999 [this issue of Cell ]). Moreover, the characteristic
changes in the mutant brains indicate that neurons inter-
pret or respond to positional information with the help
of VLDLR and ApoER2, which may therefore be signaling
receptors. These findings herald a new opportunity for
interactions between researchers in atherosclerosis and
neurobiology.
The Phenotype of VLDLR2 apoER22 Mice
Brain development is markedly altered in mice lacking
both VLDLR and ApoER2 (Trommsdorff et al., 1999). The
double mutants have obvious and highly characteristic
defects in neuronal layering in cerebral cortex, hippo-
campus, and cerebellum. Detailed analysis shows that
the VLDLR2 apoER22 phenotype is virtually identical to
that seen when either of two other genes, reln (reelin)
or dab1 (mammalian disabled-1), is mutated. Extensive
neuroanatomical and cell marking analysis of reln mu- Figure 1. Binding Interactions of the Extracellular and Intracellular
Domains of VLDLR and ApoER2tant mice, and more recent analysis of dab1 mutant
mice, has shown that the defective layering is due to Additional ligands for the extracellular domain that are not shown
here include other serine protease±protease inhibitor complexesmisplacement of committed neurons (Goldowitz et al.,
and a protein named RAP that is normally retained in the endoplas-1997; Gonzalez et al., 1997; Howell et al., 1997; Lambert
mic reticulum and probably assists extracellular domain folding.de Rouvroit and Goffinet, 1998). That is, each neuron
The direct or indirect binding of Reln to the extracellular domain is
adopts its correct fate but in the wrong place. This oc- currently speculation. Reln may instead bind to other cell surface
curs most conspicuously in the cerebral cortex, hippo- signaling molecules, or may bind to both VLDLR/ApoER2 and un-
known coreceptors.campus, and cerebellum. Each of these parts of the
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as the brain expands. It is clear that neurons in the et al., 1999). This is consistent with higher expression
affected regions of the brain can and do migrate, but of VLDLR, relative to ApoER2, in the cerebellum than
they seem to lack the ability to sense their position and in the cortex. Therefore, VLDLR and ApoER2 may be
respond appropriately. functionally redundant in a mechanistic sense, with each
A Reln±Dab1 Signaling Pathway receptor working identically and its relative importance
in Brain Development determined solely by its abundance. However, the sim-
The characterization of the reln and dab1 genes has ple hypothesis of a common molecular mechanism of
made it possible to interpret the complex neuroanatomi- action raises the question of why closely related proteins
cal defects of the mutants in terms of a signaling path- that are also expressed in the developing cortex and
way. The reln gene encodes a large glycoprotein (Reln) cerebellum, such as LRP and the LDLR, do not compen-
that is secreted by specialized neurons within restricted sate for lack of VLDLR and ApoER2 in the mutants. On
regions of the brain (D'Arcangelo et al., 1995; Ogawa et the other hand, it is also possible that the VLDLR and
al., 1995). In the cerebellar primordium, Reln is made by ApoER2 have distinct molecular mechanisms of action
the external layer of granule cells, and by the deep nu- in the cerebellum and cortex, respectively. For example,
clei, below the Purkinje cells, but not by the Purkinje cells they may interact with cerebellum-specific and cortex-
themselves. This suggests that Purkinje cell position is specific effectors, respectively. ªKnocking-inº one recep-
influenced by external signals, in the form of Reln. tor gene into the other's genomic locus may be needed
In the cortex, Reln is made by the CR neurons but to resolve the question of redundant versus specialized
not by the migratory cells (D'Arcangelo et al., 1995; functions.
Ogawa et al., 1995). Early in development, it induces a VLDLR and ApoER2 Are Likely to Be Involved
change that allows cortical neurons through the sub- in the Reln Response
plate. Later, as the CR neurons are displaced outward, In support of the functional evidence that Reln, Dab1,
the zone of Reln production marks the stopping point VLDLR, and ApoER2 may be on the same pathway,
for each wave of migrating cortical neurons. Reln may biochemical studies suggest that there may be a direct
instruct these neurons to stop migrating and to allow physical link between VLDLR or ApoER2 and Dab1 (see
subsequent arrivals to pass by. Thus, in reln2 animals, Figure 1). The Dab1 protein contains a domain that binds
cortical plate neurons can migrate but cannot pass specifically to an FXNPXY signal present in all LDLR
through the subplate or overtake other cortical plate family proteins (Trommsdorff et al., 1998). This sequence
neurons. There is also evidence that Reln influences the is also required for LDLR internalization, since it associ-
targeting of specific axons, suggesting that Reln may ates with clathrin and adaptor proteins (Kibbey et al.,
also mark the stopping points for axonal growth cones 1998). Although a complex between VLDLR or ApoER2
(Del RõÂo et al., 1997). and Dab1 has not yet been demonstrated in neurons,
The cellular responses induced by Reln, and how they such complexes do form in vitro and in heterologous
contribute to the anatomical defects, are still mysteri- cells, and would provide a molecular mechanism for
ous. In principle, changes in motility, adhesion, or gene signals to be transmitted between the receptors and
expression (e.g., of chemotaxis receptors) could be im- Dab1. It would also suggest that the receptors would
portant. One clue is that neurons from reln2 brains have work in the cells that express Dab1. Indeed, VLDLR
increased homotypic adhesion in vitro (Hoffarth et al., and ApoER2 are expressed by the neurons that express
1995; Ogawa et al., 1995). In vitro assays for Reln-regu- Dab1, as well as other cells in the cerebellum and cortex,
lated cell migration are currently unavailable but will be and are not expressed in the cells that make Reln
crucial to understanding the chain of events. (Trommsdorff et al., 1999). As in the dab12 brain,
The dab1 gene encodes a cytoplasmic, tyrosine- VLDLR2 apoER22 neurons localize as though they have
phosphorylated protein that is found in the neurons not sensed the Reln signal. In addition, Dab1 protein
whose migrations are altered in each part of the brain,
levels are increased, as in a reln2 mutant. Coupled with
including Purkinje cells and cortical plate neurons (How-
the direct binding of Dab1 to the receptors, these results
ell et al., 1997; Rice et al., 1998). Therefore, Dab1 seems
suggest that VLDLR and ApoER2 are part of the Relnlikely to be part of the response to a signal from Reln.
response pathway, although a parallel pathway cannotIndeed, Dab1 tyrosine phosphorylation is stimulated di-
be rigorously excluded at this time.rectly by Reln in neuronal cultures, and Dab1 tyrosine
Molecular Models for Signal Relayphosphorylation is reduced in the brains of embryos
Assuming a single signaling cascade raises the ques-that lack Reln (Howell et al., 1999). Thus, Reln is likely
tion: Do the receptors regulate Dab1, or conversely,to act, in whole or in part, by stimulating tyrosine phos-
does Dab1 regulate the receptors?phorylation of Dab1. Consistent with this implied order
An intriguing possibility is that VLDLR and ApoER2of events, Dab1 is not required for Reln expression, and
may be cell surface receptors or coreceptors for RelnReln has no detectable Dab1-independent functions. In
(Figure 2, left). If Reln does bind to the extracellularaddition, Reln regulates Dab1 protein levels, such that
domain of either VLDLR or ApoER2, it may allow theDab1 protein levels increase conspicuously in brains
receptor to bring its associated Dab1 close to a tyrosinethat lack Reln (Rice et al., 1998; Howell et al., 1999).
kinase for phosphorylation. Such a kinase may be con-Relative Roles of VLDLR and ApoER2
tained in the cellular compartment through which thein Brain Development
receptors cycle, such as coated pits, or may be suppliedAlthough VLDLR2 apoER22 mice phenocopy reln2 and
by a Reln coreceptor that has associated tyrosine kinasedab12 mutants, analysis of single mutants suggests that
activity. It remains to be seen whether Reln actuallythe VLDLR is more important in the cerebellum while
ApoER2 is more important in the cortex (Trommsdorff binds to VLDLR and ApoER2, and whether the receptors
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hand, lipoproteins may regulate the levels of VLDLR and
ApoER2 available for interaction with other ligands, and
thus modify the response to Reln. As a corollary, Dab1
and similar proteins that bind the internalization signal
of LDLR relatives could regulate receptor trafficking, and
thus modify lipoprotein internalization kinetics. These
possibilities remain to be explored.
Implications for Development and Aging
Mutations in some other genes cause phenotypes that
are reminiscent of some aspects of the reln2, dab12
and VLDLR2 apoER22 phenotype, suggesting they may
be involved in the same signaling events. These genes
encode a serine/threonine kinase, Cdk5, its stimulatory
subunit, p35, and the integrin a3 (Ohshima et al., 1996;
Chae et al., 1997; Anton et al., 1999). This suggests that
serine/threonine phosphorylation and integrin function
could be regulated by Dab1. However, these mutations
do not give perfect phenocopies, suggesting that theyFigure 2. Alternative Schemes for the Reln Signaling Pathway
may act on parallel pathways or on branches in theVLDLR/ApoER2 may serve as receptors (or coreceptors) for Reln,
Reln±Dab1 pathway that are important in some cellthereby inducing the tyrosine phosphorylation of Dab1 and cellular
types but not others. The existence of parallel orchanges that cause neurons to position correctly in the brain (left
panel). Alternatively, VLDLR/ApoER2 may be effectors (or coeffec- branched pathways may become apparent if compound
tors) for tyrosine-phosphorylated Dab1 (right panel). In either homozygotes show synthetic phenotypes, but these
scheme, there may be additional signals induced by Reln that may crosses have not yet been reported. In addition, a num-
cooperate with Dab1 to induce the response. A third scheme, not
ber of human genetic disorders cause defects in neu-shown, would place VLDLR/ApoER2 on a parallel pathway that is
ronal migration, but none of the mapped genes has beenrequired for the Reln response through Dab1 but is not necessarily
associated with the Reln signaling pathway. Defects inregulated by Reln.
the Reln pathway may have more serious consequences
in human development and lead to embryonic death.
In addition to a role in development, there is reason toare needed for Reln to induce Dab1 tyrosine phosphory-
believe that pathways regulated by VLDLR and ApoER2lation in vivo and in cultured neurons.
may also be involved in neurodegenerative diseases.VLDLR and ApoER2 also have the potential to be
Individuals with specific alleles of apoE, app, ps1, oreffectors for the response (Figure 2, right). For example,
ps2 are predisposed to Alzheimer's disease (Tanzi etthey may regulate migration by controlling exocytosis
al., 1996). The apoE gene encodes ApoE, which canof new membrane at the leading edge of the cell. Dab1
bind to VLDLR or ApoER2. The app gene encodes thecould regulate membrane trafficking by binding to the
amyloid precursor protein (APP), a transmembrane pro-internalization signals of VLDLR and ApoER2 and inter-
tein that contains a YXNPXY internalization signal thatacting with the vesicle transport machinery. In addition,
binds Dab1. The ps1 and ps2 genes encode presenilins;VLDLR has been shown to be a receptor for proteins
apparent proteases or protease regulators involved inthat regulate cell motility in other systems. The motility of
cleaving APP. The roles for Reln, Dab1, and the ApoEcultured epithelial cells is increased when the urokinase-
receptors in adult animals is presently unknown but nowtype plasminogen activator (uPA) binds to the cell sur-
seems ripe for exploring.face uPA receptor (uPAR) (Webb et al., 1999). The uPAR
lacks internalization signals, but the VLDLR acts as a
coreceptor for internalization. VLDLR-mediated clear- Selected Reading
ance of uPA and uPAR from the surface inhibits motility.
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